DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.70 (2024) >

このアイテムの引用には次の識別子を使用してください: http://ir.fmu.ac.jp/dspace/handle/123456789/2443

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_70_p119.pdf462.2 kBAdobe PDFダウンロード
タイトル: Current status of research on sarcopenia in post-treatment cancer survivors in Japan: A narrative review
著者: Osaki, Keiichi
Fukushima, Takuya
Suzuki, Katsuyoshi
Kamimura, Akiho
Yanai, Saki
Morishita, Shinichiro
学内所属: 理学療法学科
誌名/書名: Fukushima Journal of Medical Science
巻: 70
号: 3
開始ページ: 119
終了ページ: 131
発行日: 2024年
抄録: Sarcopenia is prevalent among 11-25% of adult cancer survivors, depending on the cancer type, although the available data on post-treatment survivors in Japan are limited. If cancer patients develop cachexia, they may experience sustained weight loss as a result, ultimately leading to sarcopenia. Conversely, some patients experience post-treatment weight gain, resulting in sarcopenic obesity. Both sarcopenia and obesity elevate the risk of cardiovascular diseases and mortality; therefore, the importance of sarcopenia prevention and management is undeniable. The Guidelines for Exercise for Cancer Survivors recommend continued physical activity. Recent studies have reported the effectiveness of multimodal interventions, combining pharmacological, nutritional, and exercise approaches, necessitating multidisciplinary care for post-treatment sarcopenia. Innovative health interventions using mobile devices have also gained attention. However, studies on sarcopenia in post-treatment cancer survivors, especially those regarding exercise interventions, remain scarce in Japan, primarily due to limited insurance coverage for such post-treatment interventions and workforce challenges. It is clear that some cancer survivors have sarcopenia, which can lead to worse survival and secondary illness. While the benefits of exercise are clear, a comprehensive approach to sarcopenia is a further challenge for the future.
出版者: The Fukushima Society of Medical Science
出版者(異表記): 福島医学会
本文の言語: eng
このページのURI: http://ir.fmu.ac.jp/dspace/handle/123456789/2443
本文URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/2443/1/FksmJMedSci_70_p119.pdf
ISSN: 0016-2590
2185-4610
DOI: 10.5387/fms.23-00019
PubMed番号: 38925958
関連ページ: https://doi.org/10.5387/fms.23-00019
権利情報: © 2024 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
権利情報: https://creativecommons.org/licenses/by-nc-sa/4.0/
出現コレクション:Vol.70 (2024)

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_70_p119.pdf462.2 kBAdobe PDFダウンロード

このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。

 

DSpace Software Copyright © 2002-2006 MIT and Hewlett-Packard